208 related articles for article (PubMed ID: 35506466)
1. Assessment of antifungal efficacy of itraconazole loaded aspasomal cream: comparative clinical study.
Lamie C; Elmowafy E; Ragaie MH; Attia DA; Mortada ND
Drug Deliv; 2022 Dec; 29(1):1345-1357. PubMed ID: 35506466
[TBL] [Abstract][Full Text] [Related]
2. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
3. Diversifying the skin cancer-fighting worthwhile frontiers: How relevant are the itraconazole/ascorbyl palmitate nanovectors?
Lamie C; Elmowafy E; Attia DA; Elmazar MM; Mortada ND
Nanomedicine; 2022 Jul; 43():102561. PubMed ID: 35417773
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid derivative-loaded modified aspasomes: formulation,
Aboul-Einien MH; Kandil SM; Abdou EM; Diab HM; Zaki MSE
J Liposome Res; 2020 Mar; 30(1):54-67. PubMed ID: 30821553
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Skin Deposition of Itraconazole Solubilized in Cream Formulation.
Kim H; Jung S; Yeo S; Kim D; Na YC; Yun G; Lee J
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31013633
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model.
Alomrani AH; Shazly GA; Amara AA; Badran MM
Colloids Surf B Biointerfaces; 2014 Sep; 121():74-81. PubMed ID: 24937135
[TBL] [Abstract][Full Text] [Related]
7. Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis.
Permana AD; Paredes AJ; Volpe-Zanutto F; Anjani QK; Utomo E; Donnelly RF
Eur J Pharm Biopharm; 2020 Sep; 154():50-61. PubMed ID: 32649991
[TBL] [Abstract][Full Text] [Related]
8. Bioadhesive-Thermosensitive
Permana AD; Utomo E; Pratama MR; Amir MN; Anjani QK; Mardikasari SA; Sumarheni S; Himawan A; Arjuna A; Usmanengsi U; Donnelly RF
ACS Appl Mater Interfaces; 2021 Apr; 13(15):18128-18141. PubMed ID: 33840187
[TBL] [Abstract][Full Text] [Related]
9. Itraconazole-loaded microemulsions: formulation, characterization, and dermal delivery using shed snakeskin as the model membrane.
Promjan S; Boonme P
Pharm Dev Technol; 2023 Jan; 28(1):51-60. PubMed ID: 36547258
[TBL] [Abstract][Full Text] [Related]
10. Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.
Qiu L; Hu B; Chen H; Li S; Hu Y; Zheng Y; Wu X
Int J Nanomedicine; 2015; 10():1415-23. PubMed ID: 25733833
[TBL] [Abstract][Full Text] [Related]
11. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
Wang J; Huang G
Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976
[TBL] [Abstract][Full Text] [Related]
12. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
13. The use of itraconazole to treat cutaneous fungal infections in children.
Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
[TBL] [Abstract][Full Text] [Related]
14. Oral therapy of common superficial fungal infections of the skin.
Lesher JL
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S31-4. PubMed ID: 10367914
[TBL] [Abstract][Full Text] [Related]
15. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
Kumar N; Shishu
Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Terbinafine Hydrochloride 1% Cream vs. Sertaconazole Nitrate 2% Cream in Tinea Corporis and Tinea Cruris: A Comparative Therapeutic Trial.
Choudhary S; Bisati S; Singh A; Koley S
Indian J Dermatol; 2013 Nov; 58(6):457-60. PubMed ID: 24249898
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
Uchida K; Yamaguchi H; Shibuya K
Jpn J Antibiot; 1991 May; 44(5):588-99. PubMed ID: 1652657
[TBL] [Abstract][Full Text] [Related]
18. Oxiconazole nitrate: pharmacology, efficacy, and safety of a new imidazole antifungal agent.
Jegasothy BV; Pakes GE
Clin Ther; 1991; 13(1):126-41. PubMed ID: 2029718
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D
J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083
[TBL] [Abstract][Full Text] [Related]
20. A pilot single centre, double blind, placebo controlled, randomized, parallel study of Calmagen® dermaceutical cream and lotion for the topical treatment of tinea and onychomycosis.
Parekh M; Ramaiah G; Pashilkar P; Ramanujam R; Johnston P; Ilag LL
BMC Complement Altern Med; 2017 Sep; 17(1):464. PubMed ID: 28923039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
